대한치과마취과학회지 (Journal of The Korean Dental Society of Anesthesiology)

  • 제12권3호
  • /
  • Pages.173-176
  • /
  • 2012
  • /
  • 1598-4044(pISSN)
  • /
  • 2383-7039(eISSN)
대한치과마취과학회 (The Korean Dental Society of Anesthsiology)
권호 표지

Large Dose Dexmedetomidine in a Patient during Sedation for Invasive Oral Procedure

  • Baek, In Yeob (Department of Anesthesia and Pain Medicine School of Medicine, Pusan National University) ;
  • Yoon, JiUk (Department of Anesthesia and Pain Medicine School of Medicine, Pusan National University) ;
  • Kim, Nam Won (Department of Anesthesia and Pain Medicine School of Medicine, Pusan National University) ;
  • Ri, Hyun Su (Department of Anesthesia and Pain Medicine School of Medicine, Pusan National University) ;
  • Kim, Cheul Hong (Department of Dental Anesthesia and Pain Medicine School of Dentistry) ;
  • Yoon, Ji Young (Department of Dental Anesthesia and Pain Medicine School of Dentistry)
  • 투고 : 2012.09.24
  • 심사 : 2012.09.27
  • 발행 : 2012.09.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Certain oral procedures require a sedated patient who is responsive to allow for the mouth opening and position change. Dexmedetomidine is a relatively selective alpha2-adrenoceptor agonist with sedative, analgesic, amnestic, and anesthetic-sparing effects. Large dose dexmedetomidine is suitable as a single agent for sedation and anxiolysis for plate removal in a patient with bilateral sagittal split osteotomy and Lefort 1 osteotomy with genioplasty.

키워드

참고문헌

  1. Aantaa R, Kanto J, Scheinin M, Kallio A, Scheinin H: Dexmedetomidine, an alpha 2-adrenoceptor agonist, reduces anesthetic requirements for patients undergoing minor gynecologic surgery. Anesthesiology 1990; 73: 230-5. https://doi.org/10.1097/00000542-199008000-00007
  2. Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ: Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. AnesthAnalg 2000; 90: 699-705.
  3. Dyck JB, Maze M, Haack C, Vuorilehto L, Shafer SL: The pharmacokinetics and hemodynamic effects of intravenous and intramuscular dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology 1993; 78: 813-20. https://doi.org/10.1097/00000542-199305000-00002
  4. Eason MG, Kurose H, Holt BD, Raymond JR, Liggett SB: Simultaneous coupling of alpha 2-adrenergic receptors to two G-proteins with opposing effects. subtype-selective coupling of alpha 2C10, alpha 2C4, and alpha 2C2 adrenergic receptors to gi and gs. J BiolChem 1992; 267: 15795-801.
  5. Philipp M, Brede M, Hein L: Physiological significance of alpha(2)-adrenergic receptor subtype diversity: One receptor is not enough. Am J PhysiolRegulIntegr Comp Physiol 2002; 283: R287-95. https://doi.org/10.1152/ajpregu.00123.2002
  6. Nelson LE, Lu J, Guo T, Saper CB, Franks NP, Maze M: The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology 2003; 98: 428-36. https://doi.org/10.1097/00000542-200302000-00024
  7. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD: The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000; 93: 382-94. https://doi.org/10.1097/00000542-200008000-00016
  8. Scher CS, Gitlin MC: Dexmedetomidine and low-dose ketamine provide adequate sedation for awakefibreoptic intubation. Can J Anaesth 2003; 50: 607-10. https://doi.org/10.1007/BF03018650
  9. Venn RM, Bryant A, Hall GM, Grounds RM: Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit. Br J Anaesth 2001; 86: 650-6. https://doi.org/10.1093/bja/86.5.650
  10. Nelson LE, Lu J, Guo T, Saper CB, Franks NP, Maze M: The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology 2003; 98: 428-36. https://doi.org/10.1097/00000542-200302000-00024
  11. Arain SR, Ebert TJ: The efficacy, side effects, and recovery characteristics of dexmedetomidine versus propofol when used for intraoperative sedation. AnesthAnalg 2002; 95: 461, 6, table of contents.
  12. Finkel JC, Johnson YJ, Quezado ZM: The use of dexmedetomidine to facilitate acute discontinuation of opioids after cardiac transplantation in children. Crit Care Med 2005; 33: 2110-2. https://doi.org/10.1097/01.CCM.0000178183.21883.23
  13. Jorden VS, Pousman RM, Sanford MM, Thorborg PA, Hutchens MP: Dexmedetomidine overdose in the perioperative setting. Ann Pharmacother 2004; 38: 803-7. https://doi.org/10.1345/aph.1D376
  14. Ramsay MA, Luterman DL: Dexmedetomidine as a total intravenous anesthetic agent. Anesthesiology 2004; 101: 787-90. https://doi.org/10.1097/00000542-200409000-00028